Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 4, 2012, Pages 423-430

  Smithson, A ^a   Chico, C ^a   Ramos, J ^a   Netto, C ^a   Sanchez, M ^a   Ruiz, J ^a   Porron, R ^a   Bastida, M T ^a  

^a HOSPITAL DE L ESPERIT SANT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; PIPEMIDIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHARLSON COMORBIDITY INDEX; CROSS-SECTIONAL STUDY; DEMENTIA; DRUG CONTRAINDICATION; DRUG USE; ESCHERICHIA COLI; FEBRILE URINARY TRACT INFECTION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INDWELLING CATHETER; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NURSING HOME PATIENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; URETHRAL CATHETER; URINARY TRACT DISEASE; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUINOLONES; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 84862891998     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1322-y     Document Type: Article

References (33)

1. Ulleryd P (2003) Febrile urinary tract infection in men. Int J Antimicrob Agents 22(Suppl 2):89-93
2. Horcajada JP, Vilana R, Moreno-Martínez A, Alvarez-Vijande R, Bru C, Bargallo X, Buñesch L, Martinez JA, Mensa J (2003) Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand J Infect Dis 35:114-120 (Pubitemid 36395276)
3. Velasco M, Mateos JJ, Martínez JA, Moreno-Martinez A, Horcajada JP, Barranco M, Lomeña F, Mensa J (2004) Accurate topographical diagnosis of urinary tract infection in male patients with (111) indium-labelled leukocyte scintigraphy. Eur J Intern Med 15:157-161 (Pubitemid 38900560)
4. Krieger JN, Nyberg L, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236-237 (Pubitemid 29343164)
5. Naber KG, Sörgel F (2003) Antibiotic therapy: rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and prostatic tissue. Andrologia 35:331-335 (Pubitemid 37363528)
6. Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, Rozwadowski J, Mehler PS, Price CS (2008) Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 121:876-884
7. European Centre for Disease Prevention and Control (2010) Antimicrobial resistance surveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)2009. Available at: http://www.ecdc.europa.eu/en/publications/Publications/1011-SUR-annual-EARS-Net- 2009. pdf. Accessed 6 January 2011
8. Killgore KM, March KL, Guglielmo BJ (2004) Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 38:1148-1152 (Pubitemid 38802150)
9. Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group (2005) Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Anti-microb Chemother 56:914-918 (Pubitemid 41631917)
10. Colodner R, Kometiani I, Chazan B, Raz R (2008) Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 36:41-45
11. Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL (2002) Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 162:2469-2477 (Pubitemid 35340464)
12. Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, Doucet J, Pfitzenmeyer P, Caron F (2008) Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 30:8-12
13. Khawcharoenporn T, Vasoo S, Ward E, Singh K (2010) High rates of quinolone resistance among urinary tract infections in the ED. Am J Emerg Med. doi:10.1016/j.ajem.2010.09.030, Epub ahead of print
14. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791-797 (Pubitemid 35334450)
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method for classifying comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383 (Pubitemid 17055592)
16. Lipsky BA, Ireton RC, Fihn SD, Hackett R, Berger RE (1987) Diagnosis of bacteriuria in men: specimen collection and culture interpretation. J Infect Dis 155:847-854 (Pubitemid 17062817)
17. CLSI (2007) Performance Standards for antimicrobial susceptibility testing: 17th informational supplement. CLSI document M100S17. Clinical and Laboratory Standard Institute, Wayne, PA
18. Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A (2008) Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168:1897-1902
19. Velasco M, Horcajada JP, Mensa J, Mensa J, Moreno-Martinez A, Vila J, Martinez JA, Ruiz J, Barranco M, Roig G, Soriano E (2001) Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 33:1682-1686 (Pubitemid 33044533)
20. Alos JI, Serrano MG, Gomez-Garces JL, Perianes J (2005) Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 11:199-203 (Pubitemid 40352766)
21. Koeijers JJ, Verbon A, Kessels AG, Bartelds A, Donkers G, Nys S, Stobberingh EE (2010) Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 76:336-340
22. Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, Tolomeo P, Wheeler M, Nachamkin I (2010) The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis 51:280-285
23. Hawkey PM (2003) Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 51(Suppl 1):29-35 (Pubitemid 36622102)
24. Tavio MM, Vila J, Ruiz J, Martin-Sanchez AM, Jimenez de Anta MT (1999) Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli. J Antimicrob Chemother 44:735-742
25. Poole K (2000) Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 44:2233-2241 (Pubitemid 30650861)
26. Poirel L, Cattoir V, Nordmann P (2008) Is plasmid-mediated quinolone resistance a clinically significant problem? Clin Microbiol Infect 14:295-297 (Pubitemid 351356518)
27. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD (2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340:c2096. doi:10.1136/bmj.c2096
28. Horcajada JP, Vila J, Moreno-Martínez A, Ruiz J, Martínez JA, Sánchez M, Soriano E, Mensa J (2002) Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 49:55-59 (Pubitemid 34100647)
29. Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O'Bryan TT, Sandberg T (2005) Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol 43:3895-3900 (Pubitemid 41129678)
30. Mazzoli S (2010) Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 59:337-344
31. Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A (2005) Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis 5:37
32. Ruiz J, Gomez J, Navia MM, Ribera A, Sierra JM, Marco F, Mensa J, Vila J (2002) High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae. Diagn Microbiol Infect Dis 42:257-261 (Pubitemid 34455017)
33. Grabe M, Bishop MC, Bjerklund-Johansen TE, Botto H, Çek M, Lobel B, Naber KG, Palou J, Tenke P, Wagenlehner F (2009) Guidelines on urological infections. European Association of Urology 2009. Available at http://www.uroweb.org/fileadmin/tx-eauguidelines/2009/Full/Urological- Infections.pdf. Accessed February 2011